John Paul Johnson Evolent Health, Inc. (EVH) insider trading activity

John Paul Johnson is Chief Financial Officer of Evolent Health, Inc.. Currently has a direct ownership of 283,784 shares of EVH, which is worth approximately $2.86 Million. The most recent transaction as insider was on Mar 03, 2025, when has been sold 26,872 shares (Class A Common Stock) at a price of $8.77 per share, resulting in proceeds of $235,667. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 284K

65.75% 3M change

31.44% 12M change

Total Value Held $2.86 Million

John Paul Johnson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 03 2025	SELL Payment of exercise price or tax liability	$235,667 $8.77 p/Share	26,872 Reduced 8.65%	283,784 Class A Common Stock
Mar 03 2025	BUY Grant, award, or other acquisition	-	148,695 Added 32.37%	310,656 Class A Common Stock
Mar 01 2025	SELL Payment of exercise price or tax liability	$83,121 $8.99 p/Share	9,246 Reduced 5.4%	161,961 Class A Common Stock
Aug 22 2024	SELL Open market or private sale	$1,340,790 $30.0 p/Share	44,693 Reduced 20.7%	171,207 Class A Common Stock
Mar 02 2024	SELL Payment of exercise price or tax liability	$310,378 $34.41 p/Share	9,020 Reduced 4.01%	215,900 Class A Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$385,839 $34.41 p/Share	11,213 Reduced 4.75%	224,920 Class A Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	12,123 Added 4.88%	236,133 Class A Common Stock
Feb 22 2024	SELL Payment of exercise price or tax liability	$660,798 $33.03 p/Share	20,006 Reduced 8.2%	224,010 Class A Common Stock
Feb 22 2024	BUY Grant, award, or other acquisition	-	44,000 Added 15.28%	244,016 Class A Common Stock
Mar 02 2023	SELL Payment of exercise price or tax liability	$317,053 $35.15 p/Share	9,020 Reduced 4.32%	200,016 Class A Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$129,792 $35.26 p/Share	3,681 Reduced 1.73%	209,036 Class A Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	20,413 Added 8.76%	212,717 Class A Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$562,302 $28.08 p/Share	20,025 Reduced 9.43%	192,304 Class A Common Stock
Feb 21 2023	BUY Grant, award, or other acquisition	-	44,000 Added 17.17%	212,329 Class A Common Stock
Aug 17 2022	SELL Open market or private sale	$628,784 $34.11 p/Share	18,434 Reduced 9.87%	168,329 Class A Common Stock
Mar 03 2022	SELL Payment of exercise price or tax liability	$890,754 $27.54 p/Share	32,344 Reduced 14.76%	186,763 Class A Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$248,411 $27.54 p/Share	9,020 Reduced 3.95%	219,107 Class A Common Stock
Mar 02 2022	BUY Exercise of conversion of derivative security	-	71,716 Added 23.92%	228,127 Class A Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$123,574 $27.4 p/Share	4,510 Reduced 2.8%	156,411 Class A Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	24,000 Added 12.98%	160,921 Class A Common Stock
Mar 01 2021	BUY Grant, award, or other acquisition	-	40,000 Added 22.61%	136,921 Class A Common Stock

JPJ

John Paul Johnson

Chief Financial Officer

Arlington, VA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EVH shares.

Notify only if

Value

Insider Trading

Get notified when an Evolent Health, Inc. insider buys or sells EVH shares.

Notify only if

Operation

Value

Type

News

Receive news related to Evolent Health, Inc.

Track Activities on EVH

Account